EX-10.11 17 d621839dex1011.htm EX-10.11 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406. OUT-LICENCE AGREEMENT by and between...Licence Agreement • May 5th, 2020 • England
Contract Type FiledMay 5th, 2020 JurisdictionNOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS INC DATE: 3RD SEPTEMBER, 2010Licence Agreement • January 29th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • England
Contract Type FiledJanuary 29th, 2014 Company Industry JurisdictionNOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS AG DATE: JUNE, 12 2009 Execution CopyLicence Agreement • January 29th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • England
Contract Type FiledJanuary 29th, 2014 Company Industry JurisdictionNOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS INC DATE: 3RD SEPTEMBER, 2010Licence Agreement • January 8th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • England
Contract Type FiledJanuary 8th, 2014 Company Industry JurisdictionNOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS AG DATE: JUNE, 12 2009 Execution CopyLicence Agreement • January 8th, 2014 • Flexion Therapeutics Inc • Pharmaceutical preparations • England
Contract Type FiledJanuary 8th, 2014 Company Industry JurisdictionNOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows: